Global Rare Disease Diagnostics Market Report 2019, Competitive Landscape, Trends and Opportunities
The Rare Disease Diagnostics market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.
The report mainly studies the size, recent trends and development status of the Rare Disease Diagnostics market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Rare Disease Diagnostics market.
Major players in the global Rare Disease Diagnostics market include:
PerkinElmer, Inc.
Illumina Inc.
Centogene A.G.
Eurofins Scientific
3billion, Inc.
GENEWIZ
Retrophin, Inc.
Laboratory Corporation of America
23andMe, Inc.
BGI, Partek, Inc.
Laboratory Corporation of America
Strand Life Sciences Pvt Ltd.
QIAGEN N.V.
On the basis of types, the Rare Disease Diagnostics market is primarily split into:
Genetic Tests
General Lab Tests
Imaging
Others
On the basis of applications, the market covers:
Hospital Laboratories
Diagnostic Laboratory
Genetic Testing Laboratories
Cancer Research Laboratories
Others
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Rare Disease Diagnostics market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Rare Disease Diagnostics market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Rare Disease Diagnostics industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Rare Disease Diagnostics market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Rare Disease Diagnostics, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Rare Disease Diagnostics in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Rare Disease Diagnostics in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Rare Disease Diagnostics. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Rare Disease Diagnostics market, including the global production and revenue forecast, regional forecast. It also foresees the Rare Disease Diagnostics market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
The report mainly studies the size, recent trends and development status of the Rare Disease Diagnostics market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Rare Disease Diagnostics market.
Major players in the global Rare Disease Diagnostics market include:
PerkinElmer, Inc.
Illumina Inc.
Centogene A.G.
Eurofins Scientific
3billion, Inc.
GENEWIZ
Retrophin, Inc.
Laboratory Corporation of America
23andMe, Inc.
BGI, Partek, Inc.
Laboratory Corporation of America
Strand Life Sciences Pvt Ltd.
QIAGEN N.V.
On the basis of types, the Rare Disease Diagnostics market is primarily split into:
Genetic Tests
General Lab Tests
Imaging
Others
On the basis of applications, the market covers:
Hospital Laboratories
Diagnostic Laboratory
Genetic Testing Laboratories
Cancer Research Laboratories
Others
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Rare Disease Diagnostics market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Rare Disease Diagnostics market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Rare Disease Diagnostics industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Rare Disease Diagnostics market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Rare Disease Diagnostics, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Rare Disease Diagnostics in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Rare Disease Diagnostics in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Rare Disease Diagnostics. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Rare Disease Diagnostics market, including the global production and revenue forecast, regional forecast. It also foresees the Rare Disease Diagnostics market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
1 RARE DISEASE DIAGNOSTICS MARKET OVERVIEW
1.1 Product Overview and Scope of Rare Disease Diagnostics
1.2 Rare Disease Diagnostics Segment by Type
1.2.1 Global Rare Disease Diagnostics Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Genetic Tests
1.2.3 The Market Profile of General Lab Tests
1.2.4 The Market Profile of Imaging
1.2.5 The Market Profile of Others
1.3 Global Rare Disease Diagnostics Segment by Application
1.3.1 Rare Disease Diagnostics Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Hospital Laboratories
1.3.3 The Market Profile of Diagnostic Laboratory
1.3.4 The Market Profile of Genetic Testing Laboratories
1.3.5 The Market Profile of Cancer Research Laboratories
1.3.6 The Market Profile of Others
1.4 Global Rare Disease Diagnostics Market by Region (2014-2026)
1.4.1 Global Rare Disease Diagnostics Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.3 Europe Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.3.1 Germany Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.3.2 UK Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.3.3 France Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.3.4 Italy Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.3.5 Spain Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.3.6 Russia Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.3.7 Poland Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.4 China Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.5 Japan Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.6 India Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.8 Central and South America Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Rare Disease Diagnostics (2014-2026)
1.5.1 Global Rare Disease Diagnostics Revenue Status and Outlook (2014-2026)
1.5.2 Global Rare Disease Diagnostics Production Status and Outlook (2014-2026)
2 GLOBAL RARE DISEASE DIAGNOSTICS MARKET LANDSCAPE BY PLAYER
2.1 Global Rare Disease Diagnostics Production and Share by Player (2014-2019)
2.2 Global Rare Disease Diagnostics Revenue and Market Share by Player (2014-2019)
2.3 Global Rare Disease Diagnostics Average Price by Player (2014-2019)
2.4 Rare Disease Diagnostics Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Rare Disease Diagnostics Market Competitive Situation and Trends
2.5.1 Rare Disease Diagnostics Market Concentration Rate
2.5.2 Rare Disease Diagnostics Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 PerkinElmer, Inc.
3.1.1 PerkinElmer, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Rare Disease Diagnostics Product Profiles, Application and Specification
3.1.3 PerkinElmer, Inc. Rare Disease Diagnostics Market Performance (2014-2019)
3.1.4 PerkinElmer, Inc. Business Overview
3.2 Illumina Inc.
3.2.1 Illumina Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Rare Disease Diagnostics Product Profiles, Application and Specification
3.2.3 Illumina Inc. Rare Disease Diagnostics Market Performance (2014-2019)
3.2.4 Illumina Inc. Business Overview
3.3 Centogene A.G.
3.3.1 Centogene A.G. Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Rare Disease Diagnostics Product Profiles, Application and Specification
3.3.3 Centogene A.G. Rare Disease Diagnostics Market Performance (2014-2019)
3.3.4 Centogene A.G. Business Overview
3.4 Eurofins Scientific
3.4.1 Eurofins Scientific Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Rare Disease Diagnostics Product Profiles, Application and Specification
3.4.3 Eurofins Scientific Rare Disease Diagnostics Market Performance (2014-2019)
3.4.4 Eurofins Scientific Business Overview
3.5 3billion, Inc.
3.5.1 3billion, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Rare Disease Diagnostics Product Profiles, Application and Specification
3.5.3 3billion, Inc. Rare Disease Diagnostics Market Performance (2014-2019)
3.5.4 3billion, Inc. Business Overview
3.6 GENEWIZ
3.6.1 GENEWIZ Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Rare Disease Diagnostics Product Profiles, Application and Specification
3.6.3 GENEWIZ Rare Disease Diagnostics Market Performance (2014-2019)
3.6.4 GENEWIZ Business Overview
3.7 Retrophin, Inc.
3.7.1 Retrophin, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Rare Disease Diagnostics Product Profiles, Application and Specification
3.7.3 Retrophin, Inc. Rare Disease Diagnostics Market Performance (2014-2019)
3.7.4 Retrophin, Inc. Business Overview
3.8 Laboratory Corporation of America
3.8.1 Laboratory Corporation of America Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Rare Disease Diagnostics Product Profiles, Application and Specification
3.8.3 Laboratory Corporation of America Rare Disease Diagnostics Market Performance (2014-2019)
3.8.4 Laboratory Corporation of America Business Overview
3.9 23andMe, Inc.
3.9.1 23andMe, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Rare Disease Diagnostics Product Profiles, Application and Specification
3.9.3 23andMe, Inc. Rare Disease Diagnostics Market Performance (2014-2019)
3.9.4 23andMe, Inc. Business Overview
3.10 BGI, Partek, Inc.
3.10.1 BGI, Partek, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Rare Disease Diagnostics Product Profiles, Application and Specification
3.10.3 BGI, Partek, Inc. Rare Disease Diagnostics Market Performance (2014-2019)
3.10.4 BGI, Partek, Inc. Business Overview
3.11 Laboratory Corporation of America
3.11.1 Laboratory Corporation of America Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Rare Disease Diagnostics Product Profiles, Application and Specification
3.11.3 Laboratory Corporation of America Rare Disease Diagnostics Market Performance (2014-2019)
3.11.4 Laboratory Corporation of America Business Overview
3.12 Strand Life Sciences Pvt Ltd.
3.12.1 Strand Life Sciences Pvt Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Rare Disease Diagnostics Product Profiles, Application and Specification
3.12.3 Strand Life Sciences Pvt Ltd. Rare Disease Diagnostics Market Performance (2014-2019)
3.12.4 Strand Life Sciences Pvt Ltd. Business Overview
3.13 QIAGEN N.V.
3.13.1 QIAGEN N.V. Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Rare Disease Diagnostics Product Profiles, Application and Specification
3.13.3 QIAGEN N.V. Rare Disease Diagnostics Market Performance (2014-2019)
3.13.4 QIAGEN N.V. Business Overview
4 GLOBAL RARE DISEASE DIAGNOSTICS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Rare Disease Diagnostics Production and Market Share by Type (2014-2019)
4.2 Global Rare Disease Diagnostics Revenue and Market Share by Type (2014-2019)
4.3 Global Rare Disease Diagnostics Price by Type (2014-2019)
4.4 Global Rare Disease Diagnostics Production Growth Rate by Type (2014-2019)
4.4.1 Global Rare Disease Diagnostics Production Growth Rate of Genetic Tests (2014-2019)
4.4.2 Global Rare Disease Diagnostics Production Growth Rate of General Lab Tests (2014-2019)
4.4.3 Global Rare Disease Diagnostics Production Growth Rate of Imaging (2014-2019)
4.4.4 Global Rare Disease Diagnostics Production Growth Rate of Others (2014-2019)
5 GLOBAL RARE DISEASE DIAGNOSTICS MARKET ANALYSIS BY APPLICATION
5.1 Global Rare Disease Diagnostics Consumption and Market Share by Application (2014-2019)
5.2 Global Rare Disease Diagnostics Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Rare Disease Diagnostics Consumption Growth Rate of Hospital Laboratories (2014-2019)
5.2.2 Global Rare Disease Diagnostics Consumption Growth Rate of Diagnostic Laboratory (2014-2019)
5.2.3 Global Rare Disease Diagnostics Consumption Growth Rate of Genetic Testing Laboratories (2014-2019)
5.2.4 Global Rare Disease Diagnostics Consumption Growth Rate of Cancer Research Laboratories (2014-2019)
5.2.5 Global Rare Disease Diagnostics Consumption Growth Rate of Others (2014-2019)
6 GLOBAL RARE DISEASE DIAGNOSTICS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Rare Disease Diagnostics Consumption by Region (2014-2019)
6.2 United States Rare Disease Diagnostics Production, Consumption, Export, Import (2014-2019)
6.3 Europe Rare Disease Diagnostics Production, Consumption, Export, Import (2014-2019)
6.4 China Rare Disease Diagnostics Production, Consumption, Export, Import (2014-2019)
6.5 Japan Rare Disease Diagnostics Production, Consumption, Export, Import (2014-2019)
6.6 India Rare Disease Diagnostics Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Rare Disease Diagnostics Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Rare Disease Diagnostics Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Rare Disease Diagnostics Production, Consumption, Export, Import (2014-2019)
7 GLOBAL RARE DISEASE DIAGNOSTICS PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Rare Disease Diagnostics Production and Market Share by Region (2014-2019)
7.2 Global Rare Disease Diagnostics Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Rare Disease Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Rare Disease Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Rare Disease Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Rare Disease Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Rare Disease Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Rare Disease Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Rare Disease Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Rare Disease Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Rare Disease Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
8 RARE DISEASE DIAGNOSTICS MANUFACTURING ANALYSIS
8.1 Rare Disease Diagnostics Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Rare Disease Diagnostics
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Rare Disease Diagnostics Industrial Chain Analysis
9.2 Raw Materials Sources of Rare Disease Diagnostics Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Rare Disease Diagnostics
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL RARE DISEASE DIAGNOSTICS MARKET FORECAST (2019-2026)
11.1 Global Rare Disease Diagnostics Production, Revenue Forecast (2019-2026)
11.1.1 Global Rare Disease Diagnostics Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Rare Disease Diagnostics Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Rare Disease Diagnostics Price and Trend Forecast (2019-2026)
11.2 Global Rare Disease Diagnostics Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Rare Disease Diagnostics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Rare Disease Diagnostics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Rare Disease Diagnostics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Rare Disease Diagnostics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Rare Disease Diagnostics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Rare Disease Diagnostics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Rare Disease Diagnostics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Rare Disease Diagnostics Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Rare Disease Diagnostics Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Rare Disease Diagnostics Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
1.1 Product Overview and Scope of Rare Disease Diagnostics
1.2 Rare Disease Diagnostics Segment by Type
1.2.1 Global Rare Disease Diagnostics Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Genetic Tests
1.2.3 The Market Profile of General Lab Tests
1.2.4 The Market Profile of Imaging
1.2.5 The Market Profile of Others
1.3 Global Rare Disease Diagnostics Segment by Application
1.3.1 Rare Disease Diagnostics Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Hospital Laboratories
1.3.3 The Market Profile of Diagnostic Laboratory
1.3.4 The Market Profile of Genetic Testing Laboratories
1.3.5 The Market Profile of Cancer Research Laboratories
1.3.6 The Market Profile of Others
1.4 Global Rare Disease Diagnostics Market by Region (2014-2026)
1.4.1 Global Rare Disease Diagnostics Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.3 Europe Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.3.1 Germany Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.3.2 UK Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.3.3 France Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.3.4 Italy Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.3.5 Spain Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.3.6 Russia Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.3.7 Poland Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.4 China Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.5 Japan Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.6 India Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.8 Central and South America Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Rare Disease Diagnostics Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Rare Disease Diagnostics (2014-2026)
1.5.1 Global Rare Disease Diagnostics Revenue Status and Outlook (2014-2026)
1.5.2 Global Rare Disease Diagnostics Production Status and Outlook (2014-2026)
2 GLOBAL RARE DISEASE DIAGNOSTICS MARKET LANDSCAPE BY PLAYER
2.1 Global Rare Disease Diagnostics Production and Share by Player (2014-2019)
2.2 Global Rare Disease Diagnostics Revenue and Market Share by Player (2014-2019)
2.3 Global Rare Disease Diagnostics Average Price by Player (2014-2019)
2.4 Rare Disease Diagnostics Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Rare Disease Diagnostics Market Competitive Situation and Trends
2.5.1 Rare Disease Diagnostics Market Concentration Rate
2.5.2 Rare Disease Diagnostics Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 PerkinElmer, Inc.
3.1.1 PerkinElmer, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Rare Disease Diagnostics Product Profiles, Application and Specification
3.1.3 PerkinElmer, Inc. Rare Disease Diagnostics Market Performance (2014-2019)
3.1.4 PerkinElmer, Inc. Business Overview
3.2 Illumina Inc.
3.2.1 Illumina Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Rare Disease Diagnostics Product Profiles, Application and Specification
3.2.3 Illumina Inc. Rare Disease Diagnostics Market Performance (2014-2019)
3.2.4 Illumina Inc. Business Overview
3.3 Centogene A.G.
3.3.1 Centogene A.G. Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Rare Disease Diagnostics Product Profiles, Application and Specification
3.3.3 Centogene A.G. Rare Disease Diagnostics Market Performance (2014-2019)
3.3.4 Centogene A.G. Business Overview
3.4 Eurofins Scientific
3.4.1 Eurofins Scientific Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Rare Disease Diagnostics Product Profiles, Application and Specification
3.4.3 Eurofins Scientific Rare Disease Diagnostics Market Performance (2014-2019)
3.4.4 Eurofins Scientific Business Overview
3.5 3billion, Inc.
3.5.1 3billion, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Rare Disease Diagnostics Product Profiles, Application and Specification
3.5.3 3billion, Inc. Rare Disease Diagnostics Market Performance (2014-2019)
3.5.4 3billion, Inc. Business Overview
3.6 GENEWIZ
3.6.1 GENEWIZ Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Rare Disease Diagnostics Product Profiles, Application and Specification
3.6.3 GENEWIZ Rare Disease Diagnostics Market Performance (2014-2019)
3.6.4 GENEWIZ Business Overview
3.7 Retrophin, Inc.
3.7.1 Retrophin, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Rare Disease Diagnostics Product Profiles, Application and Specification
3.7.3 Retrophin, Inc. Rare Disease Diagnostics Market Performance (2014-2019)
3.7.4 Retrophin, Inc. Business Overview
3.8 Laboratory Corporation of America
3.8.1 Laboratory Corporation of America Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Rare Disease Diagnostics Product Profiles, Application and Specification
3.8.3 Laboratory Corporation of America Rare Disease Diagnostics Market Performance (2014-2019)
3.8.4 Laboratory Corporation of America Business Overview
3.9 23andMe, Inc.
3.9.1 23andMe, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Rare Disease Diagnostics Product Profiles, Application and Specification
3.9.3 23andMe, Inc. Rare Disease Diagnostics Market Performance (2014-2019)
3.9.4 23andMe, Inc. Business Overview
3.10 BGI, Partek, Inc.
3.10.1 BGI, Partek, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Rare Disease Diagnostics Product Profiles, Application and Specification
3.10.3 BGI, Partek, Inc. Rare Disease Diagnostics Market Performance (2014-2019)
3.10.4 BGI, Partek, Inc. Business Overview
3.11 Laboratory Corporation of America
3.11.1 Laboratory Corporation of America Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Rare Disease Diagnostics Product Profiles, Application and Specification
3.11.3 Laboratory Corporation of America Rare Disease Diagnostics Market Performance (2014-2019)
3.11.4 Laboratory Corporation of America Business Overview
3.12 Strand Life Sciences Pvt Ltd.
3.12.1 Strand Life Sciences Pvt Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Rare Disease Diagnostics Product Profiles, Application and Specification
3.12.3 Strand Life Sciences Pvt Ltd. Rare Disease Diagnostics Market Performance (2014-2019)
3.12.4 Strand Life Sciences Pvt Ltd. Business Overview
3.13 QIAGEN N.V.
3.13.1 QIAGEN N.V. Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Rare Disease Diagnostics Product Profiles, Application and Specification
3.13.3 QIAGEN N.V. Rare Disease Diagnostics Market Performance (2014-2019)
3.13.4 QIAGEN N.V. Business Overview
4 GLOBAL RARE DISEASE DIAGNOSTICS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Rare Disease Diagnostics Production and Market Share by Type (2014-2019)
4.2 Global Rare Disease Diagnostics Revenue and Market Share by Type (2014-2019)
4.3 Global Rare Disease Diagnostics Price by Type (2014-2019)
4.4 Global Rare Disease Diagnostics Production Growth Rate by Type (2014-2019)
4.4.1 Global Rare Disease Diagnostics Production Growth Rate of Genetic Tests (2014-2019)
4.4.2 Global Rare Disease Diagnostics Production Growth Rate of General Lab Tests (2014-2019)
4.4.3 Global Rare Disease Diagnostics Production Growth Rate of Imaging (2014-2019)
4.4.4 Global Rare Disease Diagnostics Production Growth Rate of Others (2014-2019)
5 GLOBAL RARE DISEASE DIAGNOSTICS MARKET ANALYSIS BY APPLICATION
5.1 Global Rare Disease Diagnostics Consumption and Market Share by Application (2014-2019)
5.2 Global Rare Disease Diagnostics Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Rare Disease Diagnostics Consumption Growth Rate of Hospital Laboratories (2014-2019)
5.2.2 Global Rare Disease Diagnostics Consumption Growth Rate of Diagnostic Laboratory (2014-2019)
5.2.3 Global Rare Disease Diagnostics Consumption Growth Rate of Genetic Testing Laboratories (2014-2019)
5.2.4 Global Rare Disease Diagnostics Consumption Growth Rate of Cancer Research Laboratories (2014-2019)
5.2.5 Global Rare Disease Diagnostics Consumption Growth Rate of Others (2014-2019)
6 GLOBAL RARE DISEASE DIAGNOSTICS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Rare Disease Diagnostics Consumption by Region (2014-2019)
6.2 United States Rare Disease Diagnostics Production, Consumption, Export, Import (2014-2019)
6.3 Europe Rare Disease Diagnostics Production, Consumption, Export, Import (2014-2019)
6.4 China Rare Disease Diagnostics Production, Consumption, Export, Import (2014-2019)
6.5 Japan Rare Disease Diagnostics Production, Consumption, Export, Import (2014-2019)
6.6 India Rare Disease Diagnostics Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Rare Disease Diagnostics Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Rare Disease Diagnostics Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Rare Disease Diagnostics Production, Consumption, Export, Import (2014-2019)
7 GLOBAL RARE DISEASE DIAGNOSTICS PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Rare Disease Diagnostics Production and Market Share by Region (2014-2019)
7.2 Global Rare Disease Diagnostics Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Rare Disease Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Rare Disease Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Rare Disease Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Rare Disease Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Rare Disease Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Rare Disease Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Rare Disease Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Rare Disease Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Rare Disease Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
8 RARE DISEASE DIAGNOSTICS MANUFACTURING ANALYSIS
8.1 Rare Disease Diagnostics Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Rare Disease Diagnostics
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Rare Disease Diagnostics Industrial Chain Analysis
9.2 Raw Materials Sources of Rare Disease Diagnostics Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Rare Disease Diagnostics
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL RARE DISEASE DIAGNOSTICS MARKET FORECAST (2019-2026)
11.1 Global Rare Disease Diagnostics Production, Revenue Forecast (2019-2026)
11.1.1 Global Rare Disease Diagnostics Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Rare Disease Diagnostics Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Rare Disease Diagnostics Price and Trend Forecast (2019-2026)
11.2 Global Rare Disease Diagnostics Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Rare Disease Diagnostics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Rare Disease Diagnostics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Rare Disease Diagnostics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Rare Disease Diagnostics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Rare Disease Diagnostics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Rare Disease Diagnostics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Rare Disease Diagnostics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Rare Disease Diagnostics Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Rare Disease Diagnostics Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Rare Disease Diagnostics Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
